Dr. Jacqueline Lui, President of Eagle IP Group, spoke at the Breakout Session on Patent Commercialization at the 5th Annual US-China IP Conference in Shenzhen.

The conference was an annual event co-hosted by China Renmin University IP Academy, Berkeley Center for Law and Technology and Loyola Law School Los Angeles. The 5th US-China IP Conference, entitled “Intellectual Property and Economic Transformation”, brought together senior policymakers, judges, academics and international practitioners from China and the United States to discuss five important topics: (1) Recent Developments in Trade Secrets Law; (2) Privacy Protection under the Information Age; (3) Recent Developments in Entertainment Law; (4) Patent Commercialization; and (5) Brand Protection.

Our Past Events

Recommended Insights

SPC Upholds $2M RMB Award in China’s First Patent Case on a Biological Deposit

4 July 2022
On 28 Feb 2022, China’s Supreme People’s Court (SPC) issued its annual “Judgment Digests”, which includes a list of “48 typical cases” highlighting representative SPC decisions in 2021. The Judgment Digests help us understand more about the SPC’s judicial ideology, trial concepts, and adjudication methods in dealing with difficult and sophisticated legal issues as well […]

Burden Shift: CNIPA Requires Applicant to “Prove” that Post-Filing Data is not Fake Data

1 April 2025
“Good Faith” is a challenging concept that brings with it the nuances of a particular jurisdiction’s ideas about honesty, moral values, and societal expectations. Most patent laws around the world include good faith requirements – especially in matters involving the legal and the medical profession – and China is no exception. So what’s the standard? […]

Chinese Courts Cares More About Patent Quality Now (A Doctrine of Equivalents Story)

13 December 2022
There is no doubt that the drafting quality of a patent can be crucial in determining the success (or failure!) of the patent during litigation. However, due to various reasons, patents often fail to use the right drafting strategies that best protect the invention. Too often, inexperienced or unsophisticated patent drafters merely listen to an […]

China’s Newest Examination Guidelines: Inventive Step for Biological / Life Science Inventions (Part III)

30 April 2021
This is Part III of a three-part series summarizing the Examination Guidelines that were released by the CNIPA on January 15, 2021, one year to the date of Phase 1 of the US and China Economic and Trade Agreement. That agreement included specific provisions where China "shall permit pharmaceutical patent applicants to rely on supplemental […]
Top crossarrow-right